Siliq (brodalumab)

pCPA File Number: 21053
Negotiation Status:
Concluded with an LOI
Indication(s):
Psoriasis, moderate to severe plaque
Sponsor/Manufacturer:
Valeant Canada
CDA-AMC Project Number:
SR0547-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: